315 related articles for article (PubMed ID: 8836116)
21. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
Crane MS; Rossi AG; Megson IL
Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
[TBL] [Abstract][Full Text] [Related]
22. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione.
Langford EJ; Parfitt A; de Belder AJ; Marrinan MT; Martin JF
Thromb Haemost; 1997 Dec; 78(6):1516-9. PubMed ID: 9423805
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
24. S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat.
Tsikas D; Sandmann J; Luessen P; Savva A; Rossa S; Stichtenoth DO; Frölich JC
Biochim Biophys Acta; 2001 Apr; 1546(2):422-34. PubMed ID: 11295447
[TBL] [Abstract][Full Text] [Related]
25. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.
Nisoli E; Clementi E; Tonello C; Sciorati C; Briscini L; Carruba MO
Br J Pharmacol; 1998 Oct; 125(4):888-94. PubMed ID: 9831929
[TBL] [Abstract][Full Text] [Related]
26. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
27. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
28. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
29. Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function.
O'Donnell VB; Coles B; Lewis MJ; Crews BC; Marnett LJ; Freeman BA
J Biol Chem; 2000 Dec; 275(49):38239-44. PubMed ID: 10993875
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest.
Konorev EA; Joseph J; Tarpey MM; Kalyanaraman B
Br J Pharmacol; 1996 Oct; 119(3):511-8. PubMed ID: 8894171
[TBL] [Abstract][Full Text] [Related]
31. S-nitrosothiols are stored by platelets and released during platelet-neutrophil interactions.
Hirayama A; Noronha-Dutra AA; Gordge MP; Neild GH; Hothersall JS
Nitric Oxide; 1999; 3(2):95-104. PubMed ID: 10369179
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide and antimicrobial activity of reactive oxygen intermediates.
Marcinkiewicz J
Immunopharmacology; 1997 Aug; 37(1):35-41. PubMed ID: 9285242
[TBL] [Abstract][Full Text] [Related]
33. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.
Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Trovati M
Eur J Clin Invest; 2001 May; 31(5):452-61. PubMed ID: 11380598
[TBL] [Abstract][Full Text] [Related]
34. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
35. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation.
de Belder AJ; MacAllister R; Radomski MW; Moncada S; Vallance PJ
Cardiovasc Res; 1994 May; 28(5):691-4. PubMed ID: 8025915
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.
Riddell DR; Graham A; Owen JS
J Biol Chem; 1997 Jan; 272(1):89-95. PubMed ID: 8995232
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty.
Langford EJ; Brown AS; Wainwright RJ; de Belder AJ; Thomas MR; Smith RE; Radomski MW; Martin JF; Moncada S
Lancet; 1994 Nov; 344(8935):1458-60. PubMed ID: 7526102
[TBL] [Abstract][Full Text] [Related]
38. S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo.
Salas E; Langford EJ; Marrinan MT; Martin JF; Moncada S; de Belder AJ
Heart; 1998 Aug; 80(2):146-50. PubMed ID: 9813560
[TBL] [Abstract][Full Text] [Related]
39. A novel family of S-nitrosothiols: chemical synthesis and biological actions.
Al-Sa'doni HH; Khan IY; Poston L; Fisher I; Ferro A
Nitric Oxide; 2000 Dec; 4(6):550-60. PubMed ID: 11139363
[TBL] [Abstract][Full Text] [Related]
40. Adenosine 3',5'-monophosphate formation by preparations of rat liver soluble guanylate cyclase activated with nitric oxide, nitrosyl ferroheme, S-nitrosothiols, and other nitroso compounds.
McNamara DB; Kadowitz PJ; Hyman AL; Ignarro LJ
Can J Physiol Pharmacol; 1980 Dec; 58(12):1446-56. PubMed ID: 6113040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
